|
|
 |
AMMONIA Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ACACIA Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ADVIL ALLERGY SINUS Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ALUNBRIG Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ADVAIR HFA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
AKYNZEO Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
AMONDYS 45 Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|